⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1796278 | 0.93 | — | — | |
| SCHEMBL917419 | 0.89 | — | — | |
| SCHEMBL918641 | 0.84 | — | — | |
| SCHEMBL8091441 | 0.83 | — | — | |
| SCHEMBL918953 | 0.81 | TDP1 (0.31) | — | |
| SCHEMBL4593374 | 0.81 | TDP1 (0.31) | — | |
| SCHEMBL4258432 | 0.80 | — | — | |
| SCHEMBL8091437 | 0.79 | — | — | |
| SCHEMBL11801352 | 0.79 | — | — | |
| SCHEMBL5812637 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080014288-A1 | Zinc-containing treatments for hyperphosphatemia | GENZYME CORPORATION | 2008-01-17 | — | — | US | disclosed |
| EP-1830832-A1 | ZINC-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA | Genzyme Corporation (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006072054-A1 | ZINC-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA | GENZYME CORPORATION (US) | 2006-07-06 | — | — | WO | disclosed |
| US-20060002888-A1 | Polyionenes for treating infections associated with cystic fibrosis | GENZYME CORPORATION (US) | 2006-01-05 | — | — | US | disclosed |
| US-20060002889-A1 | Polyionene polymers with hydrolyzable linkages | GENZYME CORPORATION (US) | 2006-01-05 | — | — | US | disclosed |
| US-20060002887-A1 | Ionene oligomers and polymers | GENZYME CORPORATION (US) | 2006-01-05 | — | — | US | disclosed |
| WO-2004085448-A2 | UNSATURATED PHOSPHINYL-PHOSPHONATE PHOSPHATE TRANSPORT INHIBITORS | GENZYME CORPORATION (US) | 2004-10-07 | — | — | WO | disclosed |
| WO-2004046223-A2 | POLYIONENE POLYMERS WITH HYDROLYZABLE LINKAGES | GENZYME CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004046109-A2 | IONENE OLIGOMERS AND POLYMERS | GENZYME CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004045629-A1 | POLYIONENES FOR TREATING INFECTIONS ASSOCIATED WITH CYSTIC FIBROSIS | GENZYME CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004044219-A2 | XANTHENE COMPOUNDS FOR CANCER CHEMOTHERAPY | MERCURY THERAPEUTICS, INC. (US) | 2004-05-27 | — | — | WO | disclosed |
| US-20030021761-A1 | Ionene polymers and their use in treating mucositis | GELTEX PHARMACEUTICALS, INC. (US) | 2003-01-30 | — | — | US | disclosed |
| WO-2002056895-A2 | IONENE POLYMERS AND THEIR USE IN TREATING MUCOSITIS | GENZYME CORPORATION (US) | 2002-07-25 | — | — | WO | disclosed |